Enzon Pharmaceuticals, Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was USD 381,000 compared to USD 2,000 a year ago. Operating income was USD 11,000 compared to operating loss of USD 240,000 a year ago. Net income was USD 11,000 compared to net loss of USD 242,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.